EPFB
PFE icon

Employees Provident Fund Board’s Pfizer PFE Stock Holding History

Employees Provident Fund Board’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500,601
Closed -$65.7M – 88
2022
Q3 		$65.7M Sell
1,500,601
-510,370
-25% -$24.8M 1.91% 21
2022
Q2 		$105M Sell
2,010,971
-1,583,756
-44% -$80.7M 2.39% 11
2022
Q1 		$186M Buy
3,594,727
+225,727
+7% +$11.7M 3.2% 8
2021
Q4 		$199M Sell
3,369,000
-663,509
-16% -$32.9M 3.28% 9
2021
Q3 		$173M Hold
4,032,509
– – 2.86% 10
2021
Q2 		$158M Hold
4,032,509
– – 2.6% 13
2021
Q1 		$146M Buy
4,032,509
+243,401
+6% +$8.64M 2.5% 14
2020
Q4 		$139M Buy
3,789,108
+6,069
+0.2% +$223K 2.37% 14
2020
Q3 		$132M Hold
3,783,039
– – 2.76% 10
2020
Q2 		$117M Buy
3,783,039
+1,309,856
+53% +$44.5M 2.67% 12
2020
Q1 		$76.6M Buy
2,473,183
+646,800
+35% +$22M 2.08% 20
2019
Q4 		$67.9M Sell
1,826,383
-29,406
-2% -$1.05M 1.43% 28
2019
Q3 		$63.3M Buy
1,855,789
+1,236,180
+200% +$45M 1.7% 23
2019
Q2 		$25.5M Sell
619,609
-569,062
-48% -$22.6M 0.67% 45
2019
Q1 		$47.9M Hold
1,188,671
– – 1.33% 35
2018
Q4 		$49.2M Buy
1,188,671
+103,304
+10% +$4.29M 1.38% 31
2018
Q3 		$45.4M Sell
1,085,367
-425,090
-28% -$16.4M 1.25% 33
2018
Q2 		$52M Hold
1,510,457
– – 1.41% 31
2018
Q1 		$50.9M Sell
1,510,457
-369,879
-20% -$12.7M 1.52% 25
2017
Q4 		$64.6M Sell
1,880,336
-1,274,962
-40% -$43.5M 1.73% 23
2017
Q3 		$107M Buy
3,155,298
+338,643
+12% +$10.9M 3.04% 8
2017
Q2 		$89.8M Buy
2,816,655
+398,978
+17% +$12.6M 2.57% 10
2017
Q1 		$78.5M Buy
2,417,677
+156,580
+7% +$4.94M 2.29% 14
2016
Q4 		$69.7M Buy
2,261,097
+80,705
+4% +$2.46M 2.39% 16
2016
Q3 		$70.1M Sell
2,180,392
-6,159
-0.3% -$206K 2.49% 18
2016
Q2 		$73M Sell
2,186,551
-465,893
-18% -$14.9M 3.11% 13
2016
Q1 		$74.6M Sell
2,652,444
-460,089
-15% -$13.1M 3.19% 12
2015
Q4 		$95.3M Buy
3,112,533
+387,355
+14% +$12.2M 3.26% 11
2015
Q3 		$81.2M Sell
2,725,178
-558,380
-17% -$17.9M 3.09% 12
2015
Q2 		$104M Buy
3,283,558
+64,837
+2% +$2.11M 3.66% 8
2015
Q1 		$106M Sell
3,218,721
-96,555
-3% -$3.07M 3.61% 8
2014
Q4 		$98M Sell
3,315,276
-221,113
-6% -$6.34M 3% 13
2014
Q3 		$99.2M Sell
3,536,389
-106,610
-3% -$2.99M 3.13% 9
2014
Q2 		$103M Buy
3,642,999
+373,702
+11% +$10.7M 3.24% 8
2014
Q1 		$94.3M Buy
3,269,297
+210,800
+7% +$6.29M 3.04% 12
2013
Q4 		$88.9M Sell
3,058,497
-103,503
-3% -$3.01M 2.69% 16
2013
Q3 		$86.1M Sell
3,162,000
-190,554
-6% -$5.18M 3.11% 13
2013
Q2 		$89.1M Buy
+3,352,554
New +$92.6M 3.57% 9

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Employees Provident Fund Board's PFE Position: Q4 2022 in Review

Employees Provident Fund Board sold out of Pfizer (PFE) in Q4 2022, closing a stake of 1,500,601 shares — an estimated $65.7M sold.

Employees Provident Fund Board first reported a position in PFE in Q2 2013 and held it in 38 quarters. The position peaked at $199M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Employees Provident Fund Board reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Employees Provident Fund Board sold 1,500,601 Pfizer shares in Q4 2022, an estimated $65.7M.
  • Employees Provident Fund Board first reported a position in Pfizer in Q2 2013 and held it in 38 quarters.
  • Employees Provident Fund Board's Pfizer position peaked at $199M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Employees Provident Fund Board's 13F filing for Q4 2022, filed 18 Mar 2026.